SUMMARY Barrett's oesophagus is a risk factor for the development of oesophageal cancer and for this reason annual endoscopic surveillance has been proposed. In this retrospective study of all patients with Barrett's oesophagus diagnosed in a 12 year period carcinoma had developed in only four patients. The incidence of oesophageal cancer in this series was one in 170 patient years, which means a 30-fold increase compared with the general population. The survival of patients with Barrett's oesophagus was not different, however, from an age and sex matched control population. It is concluded that systematic endoscopic surveillance of patients with Barrett's oesophagus is not indicated.
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Barrett's oesophagus is a risk factor for the development of oesophageal carcinoma. '-10 In a series of 538 patients seen by the Rotterdam Oesophageal Carinoma Group the tumour was localised in Barrett's oesophagus in 55 cases: 10% ." This relatively strong correlation, however, gives no indication about the size of the risk of developing carcinoma in Barrett's oesophagus.
The prevalence of oesophageal cancer in patients with Barrett's oesophagus is sometimes erroneously advanced as an indicator of the size of this risk. The prevalence varies from 2-5 to 46% (33% in our series) and mainly reflects patients selection.12-'4
Two retrospective American surveys were recently published, which showed a 30 to 40-fold increased risk of oesophageal carcinoma in patients with Barrett's oesophagus.'5 16 The usefulness of annual endoscopic examination of patients with Barrett's oesophagus has been debated: although Spechler seems to voice some scepticism in his article: 'Adenocarcinoma and Barrett's oesophagus. An overrated risk?', almost all authors have stressed the importance of annual endoscopic surveillance.'5
The purpose of the present study was to investigate the incidence of oesophageal carcinoma in a group of patients with Barrett's oesophagus and to look for possible subgroups with increased risk. ' There was at least 10 cm Barrett's oesophagus present in all four patients against 60 patients with extended Barrett's oesophagus in the total series (Fig. 1) . (2) All four patients had undergone previous gastric surgery, against 40 in 155 of the total series. (3) Three patients had been treated for an ulcer in Barrett's oesophagus against 58 of 155 in the total series.
INCIDENCE OF OESOPHAGEAL CANCER IN PATIENTS WITH BARRETT S OESOPHAGUS
The total follow up time was 681 patient years. The incidence of oesophageal carcinoma in this series was therefore one in 170 patient years. The mean follow up was 4-4 years (three months to 12 years and five months).
INCIDENCE OF OESOPHAGEAL CANCER IN THE POPULATION
The annual mortality from carcinoma of the oesophagus in the Dutch population between 60 and 64 years is for men 210:106 and for women 50:106. 8 The expected mortality in our series of patients with Barrett's oesophagus was:
number of men incidence in men+incidence in women Although the prognosis of carcinoma of the oesophagus is unfavourable, the incidence is presumably somewhat higher than mortality, so that an annual incidence of 200: 106 could be expected in our series. This would amount to one carcinoma per 5000 patient years.
INCREASED RISK
The increased risk for carcinoma of the oesophagus in our group of patients with Barrett's oesophagus was therefore 5000:170=30 fold.
SURVIVAL CURVE
There was no significant difference between the survival curves of the follow up population and that of an age and sex matched group from the general population (Fig. 2) . The question about the usefulness of annual endoscopic surveillance in patients with Barrett's oesophagus in order to detect dysplasia and early carcinoma was raised 10 years ago. Most authors have tended to recommend this annual examination, but not always with full conviction. This advise was often based on a tendency to confuse prevalence with incidence. As carcinoma of the oesophagus is a relatively rare disease, a 30 to 40-fold increased risk needs not necessarily influence life expectancy. This becomes more obvious when the data from the three series are pooled. At a mean age of 65 years only eight of the 364 patients with Barrett's oesophagus (2.2%) had developed carcinoma of the oesophagus during a mean follow up of 5.3 years (Table) . Carcinoma of the oesophagus was the cause of death in only three of the 76 patients with Barrett's oesophagus, who died during this period. The mean age of death in our series was 74-6 years, in the Mayo Clinic study 73 years. Therefore most patients with Barrett's oesophagus died in ripe old age and only sporadically from carcinoma of the oesophagus. Our study and that of Cameron failed to show a difference in survival between patients with Barrett's oesophagus and a control population (Fig. 2) Except high grade dysplasia, the relative importance of these potential risk factors remains to be established. Endoscopic surveillance studies have so far only been published as abstracts. 24 These studies seem to be carried out in selected patients with Barrett's oesophagus and the higher incidence of oesophageal cancer in these series -which probably include more patients with extra risk factorsappears to sustain the presumption that subgroups exist, in which endoscopic surveillance has a higher yield.
It is concluded that systematic endoscopic surveillance in patients with Barrett's oesophagus is not indicated, but that from future research subgroups which are specially at risk may emerge.
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